FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36589911000001109: Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112417801000001110 Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112417901000001116 Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Is a Oxaliplatin 200mg/40ml solution for injection vials true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has active ingredient Oxaliplatin true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient Oxaliplatin true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has excipient Lactose false Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) 1 vial Has AMP True Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start